Memory Training for Mild Cognitive Impairment

N/A

Recruiting

Led By Yonas E Geda, M.D, MSc

Research Sponsored by St. Joseph's Hospital and Medical Center, Phoenix

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up will be assessed at baseline and again at a 3-month follow-up following the intervention period.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if a memory training program called CogMed can improve memory and reduce stress in individuals with early memory problems. The study will also investigate if CogMed affects a blood biom

Who is the study for?

This trial is for people over 50 with mild memory problems who can use the internet and understand English (or have a translator). They should be able to see and hear well enough for study tasks. Those with moderate or severe dementia, or an MMSE score below 19, cannot join.

What is being tested?

The study tests if CogMed, a special memory training program, improves memory in those with early signs of cognitive decline. It also examines whether CogMed affects stress levels and alters blood markers related to Alzheimer's disease.

What are the potential side effects?

Since CogMed is a non-invasive computer-based training program focusing on improving cognitive functions, it does not have typical medical side effects. However, participants may experience fatigue or frustration.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ will be assessed at baseline and again at a 3-month follow-up following the intervention period.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~will be assessed at baseline and again at a 3-month follow-up following the intervention period.

This trial's timeline: 3 weeks for screening, Varies for treatment, and will be assessed at baseline and again at a 3-month follow-up following the intervention period. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Working Memory as measured by Category Fluency Test

Working Memory as measured by the TMT-B

Working Memory as measured by the WAIS-IV Digit Span Forward/Backward

Secondary study objectives

Brief Resilience Scale (BRS) Score

Change in Blood biomarker

Cognitive Impairment as measured by the Mini Mental State Examination (MMSE)

+8 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

The Intervention Group (N = 5) Participants will be instructed to do CogMed intervention (computerized working memory activity carried out for 25 minutes daily for 5 days per week for a total of 10 weeks).

Group II: Control GroupActive Control1 Intervention

The Control group(N = 5) follow there Treatment as usual(TAU). For ethical reasons, at the end of trial, the control group will also be offered the CogMed intervention.

Do I qualify?Apply below to find out